Helix BioMedix, Inc.
HXBM
$7.18
-$0.01-0.14%
OTC PK
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Net Income | -17.49% | -14.87% | -6.09% | 9.45% | 3.09% |
| Total Depreciation and Amortization | 3.62% | -4.33% | -13.16% | -4.32% | -1.07% |
| Total Amortization of Deferred Charges | 1.20% | 314.05% | -- | -- | -- |
| Total Other Non-Cash Items | -71.13% | -52.48% | 590.34% | -29.11% | -80.79% |
| Change in Net Operating Assets | 37.69% | 207.48% | -204.28% | 4,768.00% | 98.47% |
| Cash from Operations | -28.79% | 24.36% | -36.72% | 30.27% | 9.33% |
| Capital Expenditure | -- | -- | -- | -- | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | 100.00% | -102.90% |
| Cash from Investing | 60.37% | -- | -- | 114.29% | -1,455.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.14% | 19.22% | -38.88% | 36.22% | 2.83% |